Metabolic Signatures and Potential Biomarkers for the Diagnosis and Treatment of Colon Cancer Cachexia

Scientists established a mouse model of colon cancer cachexia (CAC) and categorized the mice into three groups: CAC, noncachexia cancer, and normal control. By performing nuclear magnetic resonance-based metabolomic profiling on mouse sera, they elucidate the metabolic properties of these groups.